Conjoint Prof. Stephen Ackland
| Work Phone | (02) 4921 1146 |
|---|---|
| Fax | (02) 4968 0384 |
| Stephen.Ackland@newcastle.edu.au | |
| Position |
Conjoint Professor
Faculty of Health
|
| Office | NM2, Mater Hospital Level 3 - New Med 2 |
Biography
Prof. Stephen Ackland is Staff Specialist, Department of Medical Oncology, Calvary Mater Newcastle Hospital and Conjoint Professor, Faculty of Health, University of Newcastle. He is the Director, Hunter Translational Cancer Research Unit; Director, University of Newcastle Priority Research Centre for Cancer; Director of Clinical Cancer Research Network HNE Health; Co-director of Hunter Medical Research Institute Cancer Research Program. He has played a key role in organisation, harmonisation and enhancements of translational and clinical research locally, on a state basis and nationally. He is Editor-in-Chief, Asia-Pacific Journal of Clinical Oncology. He is an inaugural member of the PRIMe consortium (Pharmacogenomics Research towards Individualised Medicine), a NSW Cancer Council-funded collaboration of 8 NSW hospitals and research institutes with the aim of facilitating cancer pharmacogenomics research in NSW.
He has had a number of committee appointments including: Honorary Secretary, Medical Oncology Group of Australia, 1997-2000; Chairman, Medical Oncology Group of Australia, 1999-2000. Chair, Specialist Advisory Committee in Medical Oncology, RACP, 1999-2000; AMWAC Committee on Medical Oncology 1999-2001; President, Clinical Oncological Society of Australia 2004-2005; Director, Australian & New Zealand Breast Cancer Trials Group, 2007-2013; Director, NSW Cancer Council, 2006-2013.
He is the author of over 90 original publications in peer-reviewed journals and first author on 18 of these. He was co-owner of 2 patents. He has been lead investigator on 5 grants totalling $2.2m, and co-investigator on 7 grants totalling $2.6m. He has had extensive involvement in cancer clinical trials, clinical pharmacokinetics and pre-clinical pharmacology of anticancer drugs and combinations. He has been the principal investigator on two Australian multi-institutional randomised controlled trials run through cancer cooperative trials groups, and principal investigator on a number of phase I & II trials. He is/has been a member of the trial management committee of a number of cancer cooperative trials groups, undertaking multi-institutional trials in breast and GI cancer.
Qualifications
- Bachelor of Medicine & Surgery, University of Melbourne
Research
Research keywords
- Clinical Trials
- Pharmacogenomics
- Pharmacokinetics
- Pharmacology
Research expertise
- Basic and clinical pharmacology of anticancer drugs, including drug measurement, pharmacokinetics pharmacodynamics, and relevant genetics/genomics.
- Clinical trials in cancer mainly medical oncology.
Languages
- English
Fields of Research
| Code | Description | Percentage |
|---|---|---|
| 110399 | Clinical Sciences Not Elsewhere Classified | 35 |
| 111599 | Pharmacology And Pharmaceutical Sciences Not Elsewhere Classified | 35 |
| 111200 | Oncology And Carcinogenesis | 30 |
Centres and Groups
Centre
- Hunter Medical Research Institute
- PRC - Priority Research Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine
- PRC - Priority Research Centre for Cancer
- PRC - Priority Research Centre for Cancer
Group
Memberships
Committee/Associations (relevant to research).
- Am Assoc Cancer Research
Editorial Board.
- Editor - Asia Pacific Journal of Clinical Oncology
- Board member - Drug Resistance Updates
Learned Academy.
- Member - Clinical Oncological Society of Australia (Clinical Oncological Society of Australia)
- Member, ASCO International Affairs Committee 1997-99 and 2006-08
Appointments
|
Director
ANZ Breast Cancer Trials Group (Australia) |
01/07/2007 |
|
Member, scientific Advisory Committee
Australasian GI Trials Group (Australia) |
01/01/1994 |
|
Chairman
Medical Oncology Group of Australia (Australia) |
01/01/1999 - 01/01/2001 |
|
President
Clinical Oncological Soc of Australia (Australia) |
01/01/2004 - 01/01/2006 |
|
Editor
Asia Pacific Journal of Clinical Oncology (Australia) |
01/09/2004 |
|
Director
Cancer Council NSW (Australia) |
01/09/2006 |
|
Member
International Affairs Committee, Am Soc Clin Oncology (United States) |
01/09/2006 |
Administrative
Administrative expertise
Director of Medical Oncology 2001-2005. Manages the Medical Oncology research program (9 staff, clinical and lab).Chair of HMRI Cancer Research Program 2003 -present. President of Clinical Oncological Soc of Australia 2004 and 2005. Chairman, Medical Oncology Group of Australia 1999 and 2000. Board member, TheraPPy Pty Ltd 2004-2006. Board member Cancer Council NSW 2006-2009. Member, International Affairs Committee, Am Soc of Clin Oncol, 1998-2000 and 2006-2009
Teaching
Teaching keywords
- Medical Oncology
- Medicine
Teaching expertise
Teaches medical nursing and allied health students and postgraduates in basic and clinical oncology. Also science students in pharmacology